Some skincare ingredients attract attention because of a familiar name. Others require a little translation. sh-Oligopeptide-1 belongs to the second group: an ingredient with a technical label, a connection to epidermal growth factor, and a growing presence in serums marketed for smoother, younger-looking skin.

Often discussed as EGF in skincare, this biotechnology-derived ingredient raises an interesting question: can a cosmetic formula meaningfully improve skin’s appearance by drawing on the biology of cellular communication?

The research offers reasons for interest, along with reasons to keep expectations realistic. Understanding the ingredient means looking beyond phrases such as “regeneration” and asking what was actually tested, on whom, and in which formula.

What is sh-Oligopeptide-1?

sh-Oligopeptide-1 is a recombinant peptide associated with human epidermal growth factor, or EGF. A published formulation study describes it as a single-chain peptide containing 53 amino acids, produced using a synthesized gene corresponding to the human EGF gene.

Amino acids are the building blocks of proteins and peptides. Their sequence and three-dimensional arrangement influence how a molecule behaves. Matching a sequence is therefore relevant, but it does not establish that every cosmetic ingredient supply or finished serum has the same biological activity.

The prefix “sh” refers to synthetic human in cosmetic nomenclature. It describes a biotechnology approach; it should not be read as evidence that the bottle contains human skin cells. Recombinant production uses engineered biological systems to manufacture a specified molecule. On cosmetic labels, look for sh-Oligopeptide-1. Do not assume that every product advertised as a “growth factor serum,” or every ingredient with “oligopeptide” in its name, contains the same material.

Why is epidermal growth factor interesting for skin?

EGF is a signaling protein involved in cellular communication. Its biological role has motivated research into tissue repair and visible skin aging. However, natural EGF biology, medical applications of recombinant EGF, and everyday use of cosmetic sh-Oligopeptide-1 are separate evidence questions.

That distinction is central to understanding the ingredient. Research involving wounds or a procedure that disrupts the skin barrier cannot establish what an ordinary serum accomplishes on intact facial skin.

A cosmetic also has to preserve its ingredient during manufacturing, storage, and use. The material must remain suitable for its intended purpose and be delivered appropriately. An impressive explanation of a molecule’s role in the body is only the beginning of a product’s evidence story.

Potential skin benefits: what does the research show?

1. Smoother-looking texture and fine lines

An early study published in 2012 enrolled 29 women aged 39–75 in a three-month investigation of a barley-produced, human-like EGF serum. Participants used the serum twice daily alongside a basic cleanser and sunscreen. Researchers reported improvements in several appearance measures, including fine lines and texture.

Buy here

The study was open-label and lacked a vehicle-control group. Participants and investigators knew treatment was being used, and the design could not isolate the serum’s contribution from other influences. These findings support further investigation; they do not establish that every EGF-labeled cosmetic delivers equivalent results.

For a shopper, the reasonable expectation is a possible gradual improvement in skin appearance, depending on the product. Promises to erase deep wrinkles or recreate a professional lifting procedure go beyond this evidence.

2. Hydration and skin comfort within a complete formula

A 2024 study tested a cream combining sh-Oligopeptide-1, olive-derived polyphenols, and moisturizing ingredients in 30 healthy volunteers. After one week, researchers reported improvements in hydration and elasticity in the treated forearm. The reported reduction in transepidermal water loss did not reach the conventional threshold for statistical significance.

Read also: How peptides act on your skin

The cream also contained sodium hyaluronate, glycerin, and botanical ingredients. Because the formulation was a combination, the study cannot establish how much benefit came from sh-Oligopeptide-1 itself. This is a useful reminder when reading skincare claims: a moisturizing product may work well, while the contribution of its headline ingredient remains uncertain.

3. More even-looking tone: preliminary findings

A small 2018 randomized, double-blind, split-face study investigated an EGF serum in 15 women with melasma. Participants applied the serum to one side and placebo to the other for eight weeks. Researchers reported more improvement on the EGF-treated side.

Read also: The modern skincare guide

The sample was small and the findings concern a particular serum and condition. They do not establish sh-Oligopeptide-1 as a universal dark-spot treatment, or show that a cosmetic can replace a dermatologist’s melasma plan. Changes in uneven tone also should not be confused with improvement in indented scars, which involve a different structural concern.

4. What newer research adds

A 2026 randomized, double-blind pilot trial compared a recombinant EGF serum, described by its authors as oligopeptide-1, with a human-derived growth-factor formulation. Twenty women aged 50–65 participated over 12 weeks. Investigator ratings favored the recombinant formulation for selected texture and firmness outcomes, while global wrinkle scores changed little in either group.

This was a comparison of two active formulations rather than a placebo-controlled test. It also involved a small, predominantly White, female-only sample. The findings cannot establish broad effectiveness across skin types or prove that any retail sh-Oligopeptide-1 serum will perform similarly.

Why ingredient identity and biological activity matter

A critical 2023 paper questioned whether cosmetic materials described as sh-Oligopeptide-1 had adequately demonstrated the functional activity attributed to medical recombinant EGF. Its authors challenged assumptions behind several published claims.

This criticism should be attributed to those authors rather than presented as settled consensus. Nevertheless, it identifies a useful standard for evaluating products: an ingredient name alone does not establish biological activity, delivery, or clinical benefit.

A manufacturer making a substantial performance claim should be able to explain the tested material and formulation. Relevant evidence includes ingredient characterization, stability data, and a well-designed study of the finished product.

Can sh-Oligopeptide-1 penetrate skin?

Skin is a protective barrier, and delivery is a central challenge for protein-based skincare. A molecule’s size, structure, stability, and surrounding formulation influence whether it can reach a biologically relevant location. It is too simplistic to claim either that every EGF serum penetrates deeply or that every such formula must be ineffective. Different delivery systems and skin conditions complicate the question.

Read also: Hyaluronic acid in modern skincare products

Look for evidence connected to the actual product. “Encapsulated” describes a formulation strategy; it does not, by itself, demonstrate penetration or better clinical results. Likewise, results after microneedling should not be used to predict results from applying the same ingredient to undisturbed skin.

sh-Oligopeptide-1 compared with other skincare ingredients

These ingredients have different roles. Choosing among them starts with the concern you want to address.

Ingredient	Main reason it appears in a routine	Practical distinction
sh-Oligopeptide-1	Growth-factor-related approach to improving visible skin quality	Evidence depends strongly on the material and finished formula
Hyaluronic acid	Moisturizing and temporarily plumping the appearance of dry skin	Immediate hydration does not establish growth-factor activity
Niacinamide	Multifunctional support for skin appearance and barrier-focused formulas	A separate ingredient with its own concentration and formulation questions
Retinal or retinol	Retinoid approach to visible aging and texture concerns	EGF studies do not establish equivalent results or interchangeability

Combining several ingredients can create a useful product, but a long list of active ingredients is not proof of synergy. A combination should be evaluated on its own performance.

How to use a product containing sh-Oligopeptide-1

Follow the finished product’s directions. There is no universal application schedule supported for every EGF serum or cream. For a straightforward routine:

Cleanse gently.

Apply the serum or treatment as directed.

Add moisturizer if needed.

During the day, finish with broad-spectrum sunscreen used according to its label.

Introduce one new product at a time so you can identify the source of a reaction. A small-area trial can reveal an obvious intolerance, although it cannot guarantee that a later reaction will not occur. Avoid mixing separate products together in your palm unless their instructions support it. Layering directions depend on the complete formulas, rather than the ingredient names alone.

Can you combine it with retinal, vitamin C, or exfoliating acids?

There is no single compatibility rule that covers all these products. A professionally formulated combination is different from mixing independently purchased treatments. If directions are unclear, ask the manufacturer about the specific products. Using them at separate times can simplify a routine and help identify irritation; this is a practical approach, rather than proof that the ingredients are inherently incompatible.

Safety and sensible expectations

Small, short-term studies of particular EGF products have reported generally favorable tolerability. Those findings do not establish long-term safety for every material, concentration, delivery system, or user. Fragrance, preservatives, and other ingredients also affect tolerance. Stop using a product that causes a persistent rash, burning, or worsening redness.

A cosmetic serum should not be treated as a wound-care product. Use on broken skin or immediately after procedures should be guided by the treating professional. Evidence gathered under those conditions should also be interpreted separately from ordinary cosmetic use. Uncertainty is a reason to ask better questions about a formula, rather than assume either universal safety or inevitable harm.

How to choose an EGF skincare product

Before paying a premium, check whether the brand answers these questions:

- Is the exact ingredient identified on the full ingredient list?

- Was the retail formula tested, or only a supplier’s ingredient?

- Did the study include a suitable comparison group?

- Were participants similar to the people the product targets?

- Were results measured objectively, by participant opinion, or both?

- Are storage instructions and the period after opening clear?

Check what a percentage refers to. A percentage of a supplier blend may include mostly water or other carrier ingredients; it is not necessarily the percentage of active peptide. Higher headline numbers are therefore difficult to compare without an explanation. Store the product according to its label. Do not assume that refrigeration or a particular bottle style proves the protein remains active.

Find out about more interesting ingredients in moder skincare products: retinal, retinol

Frequently asked questions

Is sh-Oligopeptide-1 the same as EGF?

It is commonly discussed as a recombinant, human-EGF-related cosmetic ingredient. However, the label alone does not establish functional equivalence to a characterized medical EGF preparation. Material identity and biological activity matter.

Does sh-Oligopeptide-1 contain stem cells?

Its ingredient name describes a recombinant peptide, not a population of living stem cells. Growth factors, stem cells, and conditioned-media mixtures should not be treated as interchangeable terms.

Can it boost collagen?

Growth-factor biology provides a rationale for research, but that does not prove that every topical cosmetic increases collagen in human skin. Look for appropriate measurements from the finished product rather than an ingredient-level explanation alone.

How long does it take to work?

Facial studies discussed here assessed products over approximately eight to twelve weeks. These are study durations, not guaranteed result timelines. Immediate softness or plumping can come from the moisturizing base.

Is it better than retinol or retinal?

The studies described here do not establish superiority to either ingredient. Choose products according to your main concern, tolerance, and the evidence for the actual formulation.

Can sensitive skin use it?

Possibly, but the complete formula determines suitability. Short-term tolerability in a small study cannot guarantee comfort for someone with reactive skin.

Can it replace sunscreen?

No. An EGF-related ingredient does not establish an SPF rating or replace a sunscreen product.

The BioMaxx Skin Lab perspective

sh-Oligopeptide-1 illustrates both the promise and the complexity of biotechnology in skincare. Some studied formulations have produced encouraging changes in visible skin quality, while important questions remain about ingredient activity, delivery, and the strength of clinical evidence.

An informed routine starts with a clear goal and a product you can use consistently. For EGF-related skincare, the most persuasive reason to choose a formula is transparent evidence that connects its ingredients to a meaningful result.

Educational content only; this article does not establish that any particular BioMaxx Skin Lab product contains sh-Oligopeptide-1 or has demonstrated the outcomes discussed.

References

Mayayo T, et al. Microencapsulation, Cream Development, and Controlled Clinical Study of an Upcycled Polyphenolic Extract Combined with sh-Oligopeptide-1. Cosmetics. 2024;11(6):198. https://doi.org/10.3390/cosmetics11060198

Personal Care Products Council. INCI Nomenclature Conventions and Reference Information. https://pcpc-incipedia-cw.powerappsportals.com/INCI%20Nomenclature%20-%20Conventions%20and%20Reference%20Information.pdf

Epidermal Growth Factor in Aesthetics and Regenerative Medicine: Systematic Review. https://pubmed.ncbi.nlm.nih.gov/34566354/

Schouest JM, Luu TK, Moy RL. Improved texture and appearance of human facial skin after daily topical application of barley produced, synthetic, human-like epidermal growth factor (EGF) serum. J Drugs Dermatol. 2012;11(5):613–620. https://pubmed.ncbi.nlm.nih.gov/22527430/

Lyons A, Stoll J, Moy R. A Randomized, Double-Blind, Placebo-Controlled, Split-Face Study of the Efficacy of Topical Epidermal Growth Factor for the Treatment of Melasma. J Drugs Dermatol. 2018;17(9):970–973. https://pubmed.ncbi.nlm.nih.gov/30235384/

Abud B, et al. A Randomized, Double-Blinded Pilot Study Comparing Synthetic Versus Human-Derived Topical Epidermal Growth Factor for Facial Rejuvenation and Psychosocial Perception. J Cosmet Dermatol. 2026;25. https://doi.org/10.1111/jocd.70927

Topical application of sh-oligopeptide-1 and clinical trials with cosmetic preparations: risk or fraud? 2023. https://pubmed.ncbi.nlm.nih.gov/37452558/